MARCUS ROVIRA: Open Payments
NPI 1568455905 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,146 in 153 payments from 18 companies in 2025. Trend: 2023 $1,888 · 2024 $2,507 · 2025 $4,146
Food & beverage: $3,816Travel & lodging: $330
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 3 | $1,458 |
| ABBVIE INC. | 58 | $775 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $308 |
| Regeneron Healthcare Solutions, Inc. | 7 | $243 |
| Madrigal Pharmaceuticals | 10 | $216 |
| Phathom Pharmaceuticals, Inc. | 10 | $195 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $157 |
| QOL Medical, LLC | 6 | $133 |
| Intercept Pharmaceuticals, Inc. | 6 | $109 |
| Ipsen Biopharmaceuticals, Inc | 4 | $104 |
Products named: RINVOQ, ENTYVIO, DUPIXENT, REZDIFFRA, VOQUEZNA, Sucraid, XIFAXAN, OCALIVA.
Industry payments across LA — which companies pay providers there.
